Walleye Capital’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$107K	Sell	30,356 -792,398	-96%	-$2.53M	﹤0.01%	3644
2025 Q4	$2.25M	Buy	822,754 +786,077	+2,143%	+$1.82M	0.01%	1773
2025 Q3	$79.6K	Buy	+36,677	New	+$86.6K	﹤0.01%	3819
2025 Q1	–	Sell	-35,235	Closed	-$261K	–	4694
2024 Q4	$261K	Buy	35,235 +21,570	+158%	+$200K	﹤0.01%	3545
2024 Q3	$128K	Sell	13,665 -3,665	-21%	-$34.7K	﹤0.01%	4280
2024 Q2	$139K	Buy	+17,330	New	+$186K	﹤0.01%	4543
2024 Q1	–	Hold	0	–	–	–	5676
2023 Q4	–	Sell	-19,819	Closed	-$104K	–	5397
2023 Q3	$90.2K	Buy	+19,819	New	+$129K	﹤0.01%	3983
2023 Q2	–	Sell	-26,299	Closed	-$188K	–	4797
2023 Q1	$161K	Buy	+26,299	New	+$181K	﹤0.01%	2633
2022 Q3	–	Sell	-14,467	Closed	-$160K	–	3461
2022 Q2	$160K	Sell	14,467 -177,126	-92%	-$2.32M	﹤0.01%	1601
2022 Q1	$3.19M	Sell	191,593 -44,553	-19%	-$689K	0.09%	249
2021 Q4	$4.51M	Buy	+236,146	New	+$5.2M	0.15%	158
2021 Q2	–	Sell	-13,922	Closed	-$441	–	1430
2021 Q1	$441	Buy	+13,922	New	+$577K	0.03%	623